Paper36745340
New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy.
Liu X and 1 other. Clin Transl Oncol, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy. Papers, record 36745340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36745340
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pancreatic Neoplasms | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Humans | |
| Proteomics | |
| Gene Expression Regulation, Neoplastic | |
| Cell Line, Tumor | |
| Tumor Microenvironment |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35145909 | CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets. | Front Oncol | 2021 | https://conductscience.org/library/papers/35145909 | PubMed |
| 2 | 32296755 | Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer. | JNCI Cancer Spectr | 2020 | https://conductscience.org/library/papers/32296755 | PubMed |
| 3 | 31900901 | The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches. | Cell Oncol (Dordr) | 2020 | https://conductscience.org/library/papers/31900901 | PubMed |
| 4 | 20879979 | Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. | Curr Cancer Drug Targets | 2010 | https://conductscience.org/library/papers/20879979 | PubMed |
| 5 | 27845903 | Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. | Oncotarget | 2016 | https://conductscience.org/library/papers/27845903 | PubMed |
| 6 | 17496331 | Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. | Mol Cell Proteomics | 2007 | https://conductscience.org/library/papers/17496331 | PubMed |
| 7 | 22898815 | Matrix metalloproteinase-2 cleavage of the β1 integrin ectodomain facilitates colon cancer cell motility. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22898815 | PubMed |
| 8 | 21136992 | Profiling the potential biomarkers for cell differentiation of pancreatic cancer using iTRAQ and 2-D LC-MS/MS. | Proteomics Clin Appl | 2009 | https://conductscience.org/library/papers/21136992 | PubMed |
| 9 | 27620951 | The bad seed: Cancer stem cells in tumor development and resistance. | Drug Resist Updat | 2016 | https://conductscience.org/library/papers/27620951 | PubMed |
| 10 | 23851313 | iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. | J Proteomics | 2013 | https://conductscience.org/library/papers/23851313 | PubMed |
| 11 | 10810361 | Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice. | Anticancer Res | 2000 | https://conductscience.org/library/papers/10810361 | PubMed |
| 12 | 31591367 | Extracellular Matrix Alterations in Metastatic Processes. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31591367 | PubMed |
| 13 | 19369584 | Interaction between HSP60 and beta-catenin promotes metastasis. | Carcinogenesis | 2009 | https://conductscience.org/library/papers/19369584 | PubMed |
| 14 | 35493073 | Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35493073 | PubMed |
| 15 | 28101591 | Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression. | Arch Immunol Ther Exp (Warsz) | 2017 | https://conductscience.org/library/papers/28101591 | PubMed |
| 16 | 30668176 | Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype. | Crit Rev Biochem Mol Biol | 2018 | https://conductscience.org/library/papers/30668176 | PubMed |
| 17 | 32768595 | Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. | Gastroenterology | 2020 | https://conductscience.org/library/papers/32768595 | PubMed |
| 18 | 22050456 | Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. | J Proteome Res | 2012 | https://conductscience.org/library/papers/22050456 | PubMed |
| 19 | 25428807 | Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. | Mol Cancer | 2014 | https://conductscience.org/library/papers/25428807 | PubMed |
| 20 | 31050378 | Identification and Quantification of Proteoforms by Mass Spectrometry. | Proteomics | 2019 | https://conductscience.org/library/papers/31050378 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41024179 | Engineered exosomes: a promising approach for overcoming challenges in pancreatic cancer therapy. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41024179 | PubMed |
| 40616159 | The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice. | J Transl Med | 2025 | https://conductscience.org/library/papers/40616159 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36745340
GET https://conductscience.org/api/papers/v1/36745340/references?page=2